Literature DB >> 1430869

Refusal rates in a longitudinal study of older people: implications for field methods.

S L Tennstedt1, U Dettling, J B McKinlay.   

Abstract

Use of a carefully designed refusal conversion protocol at first follow-up in a longitudinal study of a representative sample of over 4,000 older people was investigated. Respondents who refused initially did not differ from respondents by age or gender but were more functionally independent, citing disinterest most frequently as the reason for refusal. The protocol was successful in convincing 43 percent of these initial refusals to continue participation, but less successful with proxy respondents (27% converted). Most of the refusals that were converted were done by telephone at minimal cost. Results show that it is possible, given appropriate field methods, to retain the very old and disabled in longitudinal studies.

Entities:  

Mesh:

Year:  1992        PMID: 1430869     DOI: 10.1093/geronj/47.6.s313

Source DB:  PubMed          Journal:  J Gerontol        ISSN: 0022-1422


  4 in total

1.  Spouses and unrelated friends of probands as controls for stroke genetics studies.

Authors:  Bradford Burke Worrall; Devin L Brown; Thomas G Brott; Robert D Brown; Scott L Silliman; James F Meschia
Journal:  Neuroepidemiology       Date:  2003 Jul-Aug       Impact factor: 3.282

2.  Proxy interviews and bias in the distribution of cognitive abilities due to non-response in longitudinal studies: a comparison of HRS and ELSA.

Authors:  David Weir; Jessica Faul; Kenneth Langa
Journal:  Longit Life Course Stud       Date:  2011-05

3.  [Significance of measures to optimize medical sociology research: the example of telephone survey of the elderly].

Authors:  O von dem Knesebeck; G Lüschen
Journal:  Soz Praventivmed       Date:  1999

4.  Attrition and bias in the MRC cognitive function and ageing study: an epidemiological investigation.

Authors:  Fiona E Matthews; Mark Chatfield; Carol Freeman; Cherie McCracken; Carol Brayne
Journal:  BMC Public Health       Date:  2004-04-27       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.